Abstract |
The loss of heterozygosity of genes on the short arm of chromosome 3 (3p) in human breast carcinomas occurs in a region involved in other malignancies, including renal cell carcinoma, lung cancers, and von Hippel-Lindau disease. This finding suggests the presence of a gene(s) that plays a crucial role in multiple cancers. In our study of 84 informative (heterozygous) primary breast tumors, 30% showed losses of heterozygosity on chromosome 3. The shortest region of homozygosity in primary human breast tumor is located between the DNF15S2 and RAF1 loci in the 3p21-p25 region on the short arm of chromosome 3. This region includes at least two members of the c-erbA steroid/ thyroid hormone receptor family ( c-erbA beta and c-erbA2) that may be of special relevance to breast cancer. Furthermore, tumors with a loss of heterozygosity of genes on chromosome 3 were previously reported to have frequent allelic deletions on chromosome 11p and amplification of the c-myc proto-oncogene. These results highlight the occurrence of multiple genetic alterations in breast tumors.
|
Authors | I U Ali, R Lidereau, R Callahan |
Journal | Journal of the National Cancer Institute
(J Natl Cancer Inst)
Vol. 81
Issue 23
Pg. 1815-20
(Dec 06 1989)
ISSN: 0027-8874 [Print] United States |
PMID | 2573734
(Publication Type: Journal Article)
|
Chemical References |
- DNA, Neoplasm
- MAS1 protein, human
- Proto-Oncogene Mas
- Proto-Oncogene Proteins
- Receptors, Thyroid Hormone
|
Topics |
- Breast Neoplasms
(genetics)
- Carcinoma, Intraductal, Noninfiltrating
(genetics)
- Chromosome Deletion
- Chromosome Mapping
- Chromosomes, Human, Pair 3
- DNA, Neoplasm
(analysis)
- Female
- Genotype
- Humans
- Polymorphism, Restriction Fragment Length
- Proto-Oncogene Mas
- Proto-Oncogene Proteins
(analysis)
- Receptors, Thyroid Hormone
|